ETF Sector Spotlight For 08/26/2022

ETF Sector Spotlight For 08/26/2022

Market Recap For August 26th, 2022 It would appear that Thursday might have been a case of “buy on the rumor” with Friday being the “sell on the news” situation? Regardless, Friday was a rough one. Whether or not markets are in the midst of the next leg down in an...
This Biotech Stock Is Stuck Between 2 Key Levels

This Biotech Stock Is Stuck Between 2 Key Levels

Nurix Therapeutics, Inc. is a biopharmaceutical company. It focuses on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. Take a...
ETF Sector Spotlight For 08/25/2022

ETF Sector Spotlight For 08/25/2022

Market Recap For August 25th, 2022 The major indices finally moved out of the 2+ day range they had been in and rallied into Thursday’s close. Closing near the high of the day is always a bullish sign, but there’s a lot of news on today’s docket that could throw a...
ETF Sector Spotlight For 08/24/2022

ETF Sector Spotlight For 08/24/2022

Market Recap For August 24th, 2022 Wednesday’s market was somewhat of a snoozer, with not much volatility after the initial opening bell. The major indices finished slightly in the green. Since Monday’s opening drop, the market hasn’t moved much. Eventually, stocks...
ETF Sector Spotlight For 08/23/2022

ETF Sector Spotlight For 08/23/2022

Market Recap For August 23rd, 2022 Markets declined a little further on Tuesday, but nothing major. Most stocks were in the green up until the final hour of trading. Today could be an important day when it comes to the market’s next move. If a rally can take hold,...